Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
ROKU Roku Inc
HBAN Huntington Bancshares Inc
AICAF Air China Ltd
BTZ BlackRock Credit Allocation Income Trust
SLG SL Green Realty Corp
SKT Tanger Factory Outlet Centers Inc
SJR Shaw Communications Inc
SJM J M Smucker Co
SJI South Jersey Industries Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Closing Price
$537.78
Day's Change
2.30 (0.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
546.72
Day's Low
534.10
Volume
(Light)
Volume:
620,561

10-day average volume:
1,029,910
620,561
  • Prev Close
    535.48
  • Today's Open
    534.10
  • Day's Range
    534.10-546.72
  • Avg Vol (10-day)
    1.0M
  • Last (time)
    3:59p ET 01/22/21
  • Last (size)
    10
  • 52-Wk Range
    328.13 - 664.64
    LowHigh
  • (01/31/20 - 07/20/20)
    19.09%
  • 42.9%
  • Market Cap
    57.4B
  • Shares Outstanding
    106.7M
  • 27.36
  • 19.66x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 90.64
  • (% of float 12/31/20)
    2.31

Latest News

January 21, 2021
12:01 pm ET
PR Newswire
January 19, 2021
4:15 pm ET
PR Newswire
January 12, 2021
6:09 pm ET
MarketWatch
December 30, 2020
8:41 am ET
MarketWatch
December 17, 2020
5:00 pm ET
PR Newswire
December 16, 2020
7:00 am ET
PR Newswire
December 15, 2020
6:01 am ET
Globe Newswire
December 02, 2020
10:11 am ET
BusinessWire
November 30, 2020
7:00 am ET
PR Newswire
November 25, 2020
8:46 am ET
MarketWatch
November 23, 2020
2:58 pm ET
MarketWatch
9:31 am ET
PR Newswire
November 16, 2020
7:00 am ET
PR Newswire
November 13, 2020
4:15 pm ET
PR Newswire
November 09, 2020
5:49 am ET
Globe Newswire
November 06, 2020
12:13 pm ET
MarketWatch
November 05, 2020
6:36 am ET
MarketWatch
6:34 am ET
MarketWatch
6:34 am ET
MarketWatch
6:33 am ET
MarketWatch
October 30, 2020
9:33 am ET
MarketWatch
9:20 am ET
MarketWatch
9:12 am ET
PR Newswire
October 29, 2020
2:32 pm ET
PR Newswire
12:35 pm ET
Zacks
7:00 am ET
PR Newswire
October 28, 2020
5:35 pm ET
MarketWatch
October 27, 2020
4:30 pm ET
PR Newswire
October 14, 2020
6:28 pm ET
MarketWatch
6:28 pm ET
MarketWatch
October 13, 2020
3:24 pm ET
MarketWatch
October 11, 2020
8:05 pm ET
MarketWatch
8:05 pm ET
MarketWatch
October 08, 2020
8:31 am ET
MarketWatch
4:06 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.